LuminaCare Solutions, Inc Appoints David McFarlane to Advisory Board

Boston – June 19, 2014 – LumincaCare Solutions Inc., developer of a cloud-based predictive software platform that guides treatments for serious bacterial infections, today announced it has appointed David McFarlane to its Advisory Board. Mr. McFarlane has more than 25 years of experience in building and leading companies from inception to successful initial public offering to billion dollar market capitalization. Mr. McFarlane will provide LuminaCare with guidance in the areas of business strategy and fundraising. 

David Howe, CEO and co-founder of LuminaCare Solutions, said: “We are pleased to welcome David as an advisor to LuminaCare. His expert guidance will be an essential asset to our team as we continue to grow and scale.”

David McFarlane: “I’m excited to join LuminaCare as an advisor. I worked closely with the LuminaCare team at the Venture Development Center at the University of Massachusetts over the past year where I was able to experience first-hand the promising technology they are developing.”

Mr. McFarlane has more than 25 years of experience in operations, global sales and marketing, business development, and information technology. He is currently Chief Operating Officer of Litmus Software Inc. Prior to that, he has held multiple C level positions overseeing early stage companies through scaled execution to successful IPOs and M&A exits. McFarlane holds Master of Engineering degree from Bath University in England.

About LuminaCare Solutions Inc.
LuminaCare Solutions Inc. provides a clinical decision support platform that optimizes treatments for patients with bacterial infections. LuminaCare’s proprietary technology rapidly guides the selection of the appropriate antibiotic treatments within 24 hours of diagnosis, minimizing the length of hospital stay and cost of care for each patient. With the LuminaCare platform, physicians can rapidly determine which antibiotics are susceptible or resistant to each patient’s infection, creating a true point of care solution. By rapidly selecting the right drug at the right time and dose, LuminaCare will drastically impact the healthcare system while saving millions of lives. For more information visit:


Media Contact